Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies

Theranostics. 2020 Sep 15;10(25):11462-11478. doi: 10.7150/thno.49778. eCollection 2020.

Abstract

Infections have been considered to play a critical role in the pathogenesis of IgA nephropathy (IgAN) because synpharyngitic hematuria is a common feature in IgAN. However, how infections participate in this process is still debated. More recent studies have also revealed that the alteration of the gut microbiome exerts a profound effect on host immune responses, contributing to the etiology or progression of autoimmunity. Considering IgA as the first line of defense against bacterial and viral antigens, this review evaluates the relationships among intestinal infections, gut microbiome, and IgA for a better understanding of the pathogenesis of IgAN. Moreover, as a prototype of IgA immunity, we provide detailed clarification of IgAN pathogenesis to shed light on other diseases in which IgA plays a role. Finally, we discuss potential therapies focusing on microbes and mucosal immune responses in IgAN.

Keywords: IgA nephropathy; gut microbiome; infection; mucosal immune response; therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Complement Activation / immunology
  • Disease Models, Animal
  • Gastrointestinal Microbiome / immunology*
  • Glomerular Mesangium / immunology
  • Glomerular Mesangium / pathology
  • Glomerulonephritis, IGA / immunology*
  • Glomerulonephritis, IGA / microbiology
  • Glomerulonephritis, IGA / pathology
  • Glomerulonephritis, IGA / therapy
  • Humans
  • Immunity, Mucosal*
  • Immunoglobulin A / immunology
  • Immunotherapy / methods*
  • Infections / immunology*
  • Intestinal Mucosa / immunology
  • Intestinal Mucosa / microbiology

Substances

  • Immunoglobulin A